Annual CFF
$1.29 M
-$7.63 M-85.56%
March 31, 2024
Summary
- As of March 6, 2025, AEMD annual cash flow from financing activities is $1.29 million, with the most recent change of -$7.63 million (-85.56%) on March 31, 2024.
- During the last 3 years, AEMD annual CFF has fallen by -$5.84 million (-81.94%).
- AEMD annual CFF is now -92.59% below its all-time high of $17.37 million, reached on March 31, 2022.
Performance
AEMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$7100.00
-$3300.00-86.84%
December 31, 2024
Summary
- As of March 6, 2025, AEMD quarterly cash flow from financing activities is -$7100.00, with the most recent change of -$3300.00 (-86.84%) on December 31, 2024.
- Over the past year, AEMD quarterly CFF has dropped by -$3300.00 (-86.84%).
- AEMD quarterly CFF is now -100.04% below its all-time high of $17.42 million, reached on June 30, 2021.
Performance
AEMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$5.41 M
-$184.20 K-3.29%
December 31, 2024
Summary
- As of March 6, 2025, AEMD TTM cash flow from financing activities is $5.41 million, with the most recent change of -$184.20 thousand (-3.29%) on December 31, 2024.
- Over the past year, AEMD TTM CFF has dropped by -$184.20 thousand (-3.29%).
- AEMD TTM CFF is now -71.44% below its all-time high of $18.95 million, reached on September 30, 2020.
Performance
AEMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AEMD Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.6% | -86.8% | -3.3% |
| 3 y3 years | -81.9% | -86.8% | -3.3% |
| 5 y5 years | +12.2% | -86.8% | -3.3% |
AEMD Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.6% | at low | -100.1% | +47.8% | -68.8% | +854.1% |
| 5 y | 5-year | -92.6% | +12.2% | -100.0% | +89.2% | -71.4% | +854.1% |
| alltime | all time | -92.6% | -100.0% | -100.0% | +98.6% | -71.4% | >+9999.0% |
Aethlon Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$7100.00(+86.8%) | $5.41 M(-3.3%) |
| Sep 2024 | - | -$3800.00(-100.1%) | $5.60 M(+0.1%) |
| Jun 2024 | - | $5.38 M(>+9900.0%) | $5.59 M(+334.1%) |
| Mar 2024 | $1.29 M(-85.6%) | $42.60 K(-75.9%) | $1.29 M(+3.6%) |
| Dec 2023 | - | $177.10 K(-1907.1%) | $1.24 M(+16.8%) |
| Sep 2023 | - | -$9800.00(-100.9%) | $1.06 M(-88.7%) |
| Jun 2023 | - | $1.08 M(<-9900.0%) | $9.37 M(+5.1%) |
| Mar 2023 | $8.91 M(-48.7%) | -$2600.00(+36.8%) | $8.91 M(+0.1%) |
| Dec 2022 | - | -$1900.00(-100.0%) | $8.91 M(+0.1%) |
| Sep 2022 | - | $8.30 M(+1240.0%) | $8.89 M(+1468.5%) |
| Jun 2022 | - | $619.40 K(-5943.4%) | $567.10 K(-96.7%) |
| Mar 2022 | $17.37 M(+143.6%) | -$10.60 K(-22.1%) | $17.37 M(+0.1%) |
| Dec 2021 | - | -$13.60 K(-51.6%) | $17.35 M(+0.3%) |
| Sep 2021 | - | -$28.10 K(-100.2%) | $17.30 M(-0.1%) |
| Jun 2021 | - | $17.42 M(<-9900.0%) | $17.31 M(+142.9%) |
| Mar 2021 | $7.13 M(-35.9%) | -$26.10 K(-60.5%) | $7.13 M(-50.2%) |
| Dec 2020 | - | -$66.00 K(+309.9%) | $14.32 M(-24.4%) |
| Sep 2020 | - | -$16.10 K(-100.2%) | $18.95 M(+2.7%) |
| Jun 2020 | - | $7.24 M(+0.9%) | $18.45 M(+65.8%) |
| Mar 2020 | $11.13 M(+869.7%) | $7.17 M(+57.3%) | $11.13 M(+155.4%) |
| Dec 2019 | - | $4.56 M(-986.0%) | $4.36 M(+589.7%) |
| Sep 2019 | - | -$514.40 K(+490.6%) | $631.70 K(-42.2%) |
| Jun 2019 | - | -$87.10 K(-121.7%) | $1.09 M(-4.7%) |
| Mar 2019 | $1.15 M(-87.7%) | $400.60 K(-51.9%) | $1.15 M(-63.3%) |
| Dec 2018 | - | $832.60 K(-1670.9%) | $3.13 M(-59.8%) |
| Sep 2018 | - | -$53.00 K(+62.1%) | $7.78 M(-17.7%) |
| Jun 2018 | - | -$32.70 K(-101.4%) | $9.45 M(+1.1%) |
| Mar 2018 | $9.35 M(+216.1%) | $2.38 M(-56.5%) | $9.35 M(+5.5%) |
| Dec 2017 | - | $5.48 M(+238.0%) | $8.87 M(+108.8%) |
| Sep 2017 | - | $1.62 M(-1308.2%) | $4.25 M(+50.4%) |
| Jun 2017 | - | -$134.20 K(-107.1%) | $2.82 M(-4.5%) |
| Mar 2017 | $2.96 M(-47.2%) | $1.90 M(+120.6%) | $2.96 M(+179.1%) |
| Dec 2016 | - | $860.50 K(+331.8%) | $1.06 M(+395.0%) |
| Sep 2016 | - | $199.30 K(>+9900.0%) | $214.10 K(+1346.6%) |
| Jun 2016 | - | $0.00(0.0%) | $14.80 K(-99.7%) |
| Mar 2016 | $5.61 M(+20.5%) | $0.00(-100.0%) | $5.61 M(+0.4%) |
| Dec 2015 | - | $14.80 K(>+9900.0%) | $5.58 M(-41.7%) |
| Sep 2015 | - | $0.00(-100.0%) | $9.58 M(-3.5%) |
| Jun 2015 | - | $5.59 M(<-9900.0%) | $9.93 M(+113.2%) |
| Mar 2015 | $4.65 M(+38.5%) | -$22.50 K(-100.6%) | $4.65 M(-0.2%) |
| Dec 2014 | - | $4.01 M(+1046.5%) | $4.66 M(+37.0%) |
| Sep 2014 | - | $349.50 K(+8.9%) | $3.40 M(-4.2%) |
| Jun 2014 | - | $320.80 K(-2238.7%) | $3.55 M(+5.7%) |
| Mar 2014 | $3.36 M(+61.5%) | -$15.00 K(-100.5%) | $3.36 M(-14.1%) |
| Dec 2013 | - | $2.75 M(+449.4%) | $3.91 M(+135.1%) |
| Sep 2013 | - | $500.00 K(+290.6%) | $1.66 M(+15.9%) |
| Jun 2013 | - | $128.00 K(-76.2%) | $1.44 M(-31.0%) |
| Mar 2013 | $2.08 M(+5.5%) | $538.80 K(+8.2%) | $2.08 M(+0.5%) |
| Dec 2012 | - | $498.00 K(+83.8%) | $2.07 M(+6.4%) |
| Sep 2012 | - | $271.00 K(-64.9%) | $1.95 M(-11.6%) |
| Jun 2012 | - | $772.40 K(+45.9%) | $2.20 M(+11.8%) |
| Mar 2012 | $1.97 M | $529.40 K(+41.4%) | $1.97 M(+17.4%) |
| Dec 2011 | - | $374.30 K(-29.1%) | $1.68 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $527.70 K(-2.3%) | $1.60 M(-23.8%) |
| Jun 2011 | - | $540.00 K(+128.0%) | $2.11 M(+9.4%) |
| Mar 2011 | $1.93 M(-7.0%) | $236.80 K(-21.1%) | $1.93 M(-16.6%) |
| Dec 2010 | - | $300.00 K(-70.9%) | $2.31 M(-5.0%) |
| Sep 2010 | - | $1.03 M(+187.2%) | $2.43 M(+22.9%) |
| Jun 2010 | - | $358.60 K(-42.1%) | $1.98 M(-4.4%) |
| Mar 2010 | $2.07 M(+34.3%) | $619.80 K(+46.9%) | $2.07 M(+26.0%) |
| Dec 2009 | - | $422.00 K(-26.9%) | $1.64 M(+0.3%) |
| Sep 2009 | - | $577.40 K(+28.3%) | $1.64 M(+9.9%) |
| Jun 2009 | - | $450.20 K(+133.0%) | $1.49 M(-3.2%) |
| Mar 2009 | $1.54 M(-20.2%) | $193.20 K(-53.7%) | $1.54 M(-16.9%) |
| Dec 2008 | - | $417.50 K(-2.9%) | $1.85 M(-9.2%) |
| Sep 2008 | - | $430.00 K(-14.0%) | $2.04 M(-16.0%) |
| Jun 2008 | - | $500.00 K(-1.5%) | $2.43 M(+25.9%) |
| Mar 2008 | $1.93 M(+43.3%) | $507.40 K(-16.1%) | $1.93 M(-14.6%) |
| Dec 2007 | - | $605.00 K(-26.0%) | $2.26 M(+19.9%) |
| Sep 2007 | - | $817.90 K(>+9900.0%) | $1.88 M(+56.2%) |
| Jun 2007 | - | $0.00(-100.0%) | $1.21 M(-10.4%) |
| Mar 2007 | $1.35 M(-44.5%) | $836.70 K(+263.8%) | $1.35 M(-17.6%) |
| Dec 2006 | - | $230.00 K(+64.3%) | $1.64 M(-13.7%) |
| Sep 2006 | - | $140.00 K(0.0%) | $1.90 M(-16.1%) |
| Jun 2006 | - | $140.00 K(-87.6%) | $2.26 M(-6.9%) |
| Mar 2006 | $2.43 M(+52.1%) | $1.13 M(+129.6%) | $2.43 M(+40.5%) |
| Dec 2005 | - | $490.00 K(-3.0%) | $1.73 M(+2.6%) |
| Sep 2005 | - | $505.00 K(+64.2%) | $1.68 M(+44.1%) |
| Jun 2005 | - | $307.60 K(-27.7%) | $1.17 M(-26.8%) |
| Mar 2005 | $1.60 M(+194.5%) | $425.50 K(-4.5%) | $1.60 M(+22.5%) |
| Dec 2004 | - | $445.40 K(-4554.0%) | $1.30 M(+35.4%) |
| Sep 2004 | - | -$10.00 K(-101.4%) | $962.60 K(-14.6%) |
| Jun 2004 | - | $735.50 K(+456.8%) | $1.13 M(+108.0%) |
| Mar 2004 | $542.10 K(-3.3%) | $132.10 K(+25.8%) | $542.10 K(-3.9%) |
| Dec 2003 | - | $105.00 K(-32.3%) | $563.90 K(+0.4%) |
| Sep 2003 | - | $155.00 K(+3.3%) | $561.40 K(-10.9%) |
| Jun 2003 | - | $150.00 K(-2.5%) | $630.40 K(+12.5%) |
| Mar 2003 | $560.40 K(-48.6%) | $153.90 K(+50.1%) | $560.40 K(-14.6%) |
| Dec 2002 | - | $102.50 K(-54.2%) | $656.50 K(-0.1%) |
| Sep 2002 | - | $224.00 K(+180.0%) | $657.00 K(+36.7%) |
| Jun 2002 | - | $80.00 K(-68.0%) | $480.50 K(-55.9%) |
| Mar 2002 | $1.09 M(+52.7%) | $250.00 K(+142.7%) | $1.09 M(+13.5%) |
| Dec 2001 | - | $103.00 K(+116.8%) | $959.80 K(-18.1%) |
| Sep 2001 | - | $47.50 K(-93.1%) | $1.17 M(-10.0%) |
| Jun 2001 | - | $689.30 K(+474.4%) | $1.30 M(+82.4%) |
| Mar 2001 | $713.70 K(-23.9%) | $120.00 K(-61.9%) | $713.80 K(-29.9%) |
| Dec 2000 | - | $315.00 K(+77.5%) | $1.02 M(+1.4%) |
| Sep 2000 | - | $177.50 K(+75.2%) | $1.00 M(+2.6%) |
| Jun 2000 | - | $101.30 K(-76.2%) | $979.10 K(+4.4%) |
| Mar 2000 | $937.70 K(+652.6%) | $424.80 K(+41.4%) | $937.80 K(+82.8%) |
| Dec 1999 | - | $300.50 K(+97.0%) | $513.00 K(+141.4%) |
| Sep 1999 | - | $152.50 K(+154.2%) | $212.50 K(+254.2%) |
| Jun 1999 | - | $60.00 K | $60.00 K |
| Mar 1999 | $124.60 K(-12.3%) | - | - |
| Mar 1998 | $142.00 K(>+9900.0%) | - | - |
| Mar 1997 | $0.00 | - | - |
FAQ
- What is Aethlon Medical annual cash flow from financing activities?
- What is the all time high annual CFF for Aethlon Medical?
- What is Aethlon Medical annual CFF year-on-year change?
- What is Aethlon Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Aethlon Medical?
- What is Aethlon Medical quarterly CFF year-on-year change?
- What is Aethlon Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Aethlon Medical?
- What is Aethlon Medical TTM CFF year-on-year change?
What is Aethlon Medical annual cash flow from financing activities?
The current annual CFF of AEMD is $1.29 M
What is the all time high annual CFF for Aethlon Medical?
Aethlon Medical all-time high annual cash flow from financing activities is $17.37 M
What is Aethlon Medical annual CFF year-on-year change?
Over the past year, AEMD annual cash flow from financing activities has changed by -$7.63 M (-85.56%)
What is Aethlon Medical quarterly cash flow from financing activities?
The current quarterly CFF of AEMD is -$7100.00
What is the all time high quarterly CFF for Aethlon Medical?
Aethlon Medical all-time high quarterly cash flow from financing activities is $17.42 M
What is Aethlon Medical quarterly CFF year-on-year change?
Over the past year, AEMD quarterly cash flow from financing activities has changed by -$3300.00 (-86.84%)
What is Aethlon Medical TTM cash flow from financing activities?
The current TTM CFF of AEMD is $5.41 M
What is the all time high TTM CFF for Aethlon Medical?
Aethlon Medical all-time high TTM cash flow from financing activities is $18.95 M
What is Aethlon Medical TTM CFF year-on-year change?
Over the past year, AEMD TTM cash flow from financing activities has changed by -$184.20 K (-3.29%)